The Chimerix CMX001 Registry
Condition(s):Outcomes; Survival RatesLast Updated:May 17, 2019Terminated
Hide Studies Not Open or Pending
Condition(s):Outcomes; Survival RatesLast Updated:May 17, 2019Terminated
Condition(s):Non Squamous Non Small Cell Lung CancerLast Updated:June 8, 2018Completed
Condition(s):Refractory or Recurrent Solid Tumors, Excluding CNS TumorsLast Updated:January 29, 2018Completed
Condition(s):Migraine HeadacheLast Updated:November 23, 2018Completed
Condition(s):Metastatic Breast CancerLast Updated:February 23, 2024Completed
Condition(s):Pelvic Organ ProlapseLast Updated:January 27, 2022Completed
Condition(s):Chronic Hepatitis CLast Updated:January 29, 2016No longer available
Condition(s):Diabetic NeuropathyLast Updated:March 20, 2020Completed
Condition(s):Adult Attention Deficit Hyperactivity DisorderLast Updated:May 2, 2017Completed
Condition(s):Solid Tumor; Hematologic MalignanciesLast Updated:June 18, 2019Terminated
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.